Yun-Xin Lu
Overview
Explore the profile of Yun-Xin Lu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
1658
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Luo H, Lu Y, Shitara K, Lenz H, Xu R
Cancer Cell
. 2025 Feb;
PMID: 40020671
Translating basic cancer biology into effective clinical therapies remains a major challenge due to differences in research models, communication gaps, and limited funding. This commentary underscores the transformative potential of...
2.
Ju H, Zhuang Z, Li H, Tian T, Lu Y, Fan X, et al.
Cancer Lett
. 2025 Feb;
615:217562.
PMID: 39984383
No abstract available.
3.
Chen D, Lu Y, Zhang J, Wei X, Wang F, Zeng Z, et al.
Theranostics
. 2025 Feb;
15(5):2086-2087.
PMID: 39897561
[This corrects the article DOI: 10.7150/thno.20942.].
4.
Ju H, Lu Y, Chen D, Tian T, Mo H, Wei X, et al.
Theranostics
. 2025 Feb;
15(5):2090-2091.
PMID: 39897547
[This corrects the article DOI: 10.7150/thno.14848.].
5.
Luo X, Lu Y, Wang Y, Huang R, Liu J, Jin Y, et al.
Cancer Lett
. 2024 Jul;
598:217085.
PMID: 38964733
LncRNA plays a crucial role in cancer progression and targeting, but it has been difficult to identify the critical lncRNAs involved in colorectal cancer (CRC) progression. We identified FAM83H-AS1 as...
6.
Wu Q, Qi J, Liu Z, Luo X, Yu K, Lu Y, et al.
Cancer Lett
. 2024 Jan;
584:216643.
PMID: 38246220
In the realm of cancer therapeutics and resistance, kinases play a crucial role, particularly in gastric cancer (GC). Our study focused on platinum-based chemotherapy resistance in GC, revealing a significant...
7.
Zhang Z, Lu Y, Liu F, Sang L, Shi C, Xie S, et al.
Proc Natl Acad Sci U S A
. 2023 Feb;
120(8):e2206694120.
PMID: 36795754
Notch has been implicated in human cancers and is a putative therapeutic target. However, the regulation of Notch activation in the nucleus remains largely uncharacterized. Therefore, characterizing the detailed mechanisms...
8.
Yu H, Wang F, Yu F, Zeng Z, Wang Y, Lu Y, et al.
Cell Death Dis
. 2023 Jan;
14(1):46.
PMID: 36670108
No abstract available.
9.
Meng Q, Lu Y, Wei C, Wang Z, Lin J, Liao K, et al.
Oncogene
. 2022 Jul;
41(32):3912-3924.
PMID: 35798877
Metastasis accounts for the major cause of cancer-related mortality. How disseminated tumor cells survive under suspension conditions and avoid anoikis is largely unknown. Here, using a metabolic enzyme-centered CRISPR-Cas9 genetic...
10.
Zhang X, Lai L, Zhou H, Mo Y, Lu X, Liu M, et al.
PLoS One
. 2022 May;
17(5):e0268779.
PMID: 35594278
Background: The efficacy and safety of stereotactic body radiotherapy (SBRT) plus transcatheter arterial chemoembolization (TACE) versus SBRT or TACE alone(monotherapy) for hepatocellular carcinoma (HCC) patients with portal vein tumour thrombus...